This guideline from the National Institute for Health and Care Excellence (NICE) covers assessment, management and preventing recurrence for children, young people and adults who have self-harmed. It includes those with a mental health problem, neurodevelopmental disorder or learning disability and applies to all sectors that work with people who have self-harmed.
The final guideline mirrors the draft guidance in advising that self-harming patients, when treated in primary care, must receive:
- regular follow-up appointments
- regular reviews of self-harm behaviour
- a regular medicines review.
The guidance also said:
- After an episode of self-harm, the format and frequency of initial aftercare and which services will be involved must be discussed with the patient.
- If the psychosocial assessment after a self-harm episode was made by a GP, initial aftercare must be provided by the GP within 48 hours of the assessment.
- GPs should use consultations and medicines reviews as ‘an opportunity to assess self-harm if appropriate, for example, asking about thoughts of self-harm or suicide, actual self-harm, and access to substances that might be taken in overdose (including prescribed, over-the-counter medicines, herbal remedies and recreational drugs)’.
Reiterating existing guidance, the guideline added: ‘Do not offer drug treatment as a specific intervention to reduce self-harm.’
Self-harm: assessment, management and preventing recurrence (NICE, 7 September 2022) https://www.nice.org.uk/guidance/ng225
0 reactions so far
There are no comments to display.
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!Register a new account
Already have an account? Sign in here.Sign In Now